Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 18Leukemia 8Multiple Myeloma 7Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Biphenotypic, Acute 5Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Breast Neoplasms 4Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Congenital Abnormalities 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Smoldering Multiple Myeloma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

Melphalan 2Transplantation, Autologous 1Peripheral Blood Stem Cell Transplantation 1Lenalidomide 1In Situ Hybridization, Fluorescence 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dexamethasone 1Cytogenetic Analysis 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Smoldering Multiple Myeloma × Granulocyte Colony-Stimulating Factor × Clear all
NCT00112827 2025-06-06

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

City of Hope Medical Center

Phase 1/2 Completed
54 enrolled 13 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡